DeepMed Research

Oregon Health and Science University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Changes in the Bladder Micro-environment Following Midurethral Sling Surgery for Stress Urinary Incontinence

Conditions: Stress Urinary Incontinence

Interventions: Device: Retropubic midurethral sling

First Posted Date: 2019-05-08

Last Posted Date: 2020-09-16

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 20

Registration Number: NCT03942549

Locations: 🇺🇸
Legacy Good Samaritan Hospital, Portland, Oregon, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment

Early Phase 1

Terminated

Conditions: Cognitive Impairment
Elderly

Interventions: Drug: 2g Centella asiatica water extract product
Drug: 4g Centella asiatica water extract product

First Posted Date: 2019-05-06

Last Posted Date: 2022-05-04

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 5

Registration Number: NCT03937908

Locations: 🇺🇸
Oregon Health and Science University Department of Neurology, Portland, Oregon, United States

Delivering Early Intervention to Children With Down Syndrome

Not Applicable

Completed

Conditions: Down Syndrome

Interventions: Behavioral: Enhanced Milieu teaching

First Posted Date: 2019-05-02

Last Posted Date: 2022-03-02

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 3

Registration Number: NCT03935620

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

Vascular Cardiotoxicity of Ponatinib

Conditions: Cardiotoxicity

First Posted Date: 2019-04-29

Last Posted Date: 2019-06-07

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 32

Registration Number: NCT03930394

Locations: 🇺🇸
Oregon HSU, Portland, Oregon, United States

Pharmacokinetics of Centella Asiatica in the Elderly

Early Phase 1

Active, not recruiting

Conditions: Healthy
Elderly

Interventions: Drug: 2g Centella asiatica water extract product
Drug: 4g Centella asiatica water extract product

First Posted Date: 2019-04-26

Last Posted Date: 2023-11-03

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 8

Registration Number: NCT03929250

Locations: 🇺🇸
Oregon Health and Science University Department of Neurology, Portland, Oregon, United States

WF and PR OCTA in Diabetic Retinopathy

Active, not recruiting

Conditions: Diabetic Retinopathy

First Posted Date: 2019-04-22

Last Posted Date: 2024-02-12

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 290

Registration Number: NCT03922932

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

VAPORHCS/OHSU J: MRI and Devices

Not Applicable

Recruiting

Conditions: MRI

Interventions: Diagnostic Test: MRI

First Posted Date: 2019-04-16

Last Posted Date: 2024-04-15

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 10000

Registration Number: NCT03915015

Locations: 🇺🇸
Oregon Health and Scince University, Portland, Oregon, United States
🇺🇸
Portland Veterans Administration Medical Center, Portland, Oregon, United States

Oxytocin Receptor Expression in Pregnancy

Active, not recruiting

Conditions: Post-Abortion
Hemorrhage, Obstetric

Interventions: Other: Myometrial tissue sample collection

First Posted Date: 2019-04-09

Last Posted Date: 2024-03-29

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 30

Registration Number: NCT03907735

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Clinical Utility of Pharmacogenomics of Psychotropic Medications

Phase 4

Withdrawn

Conditions: Psychiatric Disorders
Pain

Interventions: Drug: Genetically-guided treatment with FDA-approved psychotropic drugs
Drug: Treatment as usual (TAU)

First Posted Date: 2019-04-08

Last Posted Date: 2023-09-21

Lead Sponsor: Oregon Health and Science University

Registration Number: NCT03907124

Locations: 🇺🇸
Mujeeb Uddin Shad, Salem, Oregon, United States

Reducing Overdose After Release From Incarceration

Completed

Conditions: Overdose, Drug

First Posted Date: 2019-04-04

Last Posted Date: 2024-04-17

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 65

Registration Number: NCT03902821

Locations: 🇺🇸
Oregon Department of Corrections, Wilsonville, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy